Table 1.
Included Guidelines for Augmentation Treatments in Unipolar Depression
| Guideline | Region | Year |
|---|---|---|
| APA (American Psychiatric Association, 2010) | North America | 2010 |
| BAP (Cleare et al., 2015) | Europe | 2015 |
| CANMAT (Kennedy et al., 2016) | North America | 2016 |
| CPG-S (Ministry of Health, Social Services and Equality, Galician Agency for Health et al., 2014) | Europe | 2014 |
| ICSI (Trangle et al., 2016) | North America | 2016 |
| MPG (Taylor, David M. et al., 2018) | Europe | 2018 |
| NICE (NICE, 2009) | Europe | 2009 |
| RANZCP (Malhi et al., 2015) | Australasia | 2015 |
| TMAP (Suehs et al., 2008) | North America | 2008 |
| WFSBP (Bauer et al., 2013b, 2015)a | Worldwide | 2013/2015 |
Abbreviations: APA, American Psychiatric Association; BAP, British Association of Psychopharmacology; CANMAT, Canadian Network for Mood and Anxiety Disorders; CPG-S, Clinical Practice Guidelines in the Spanish National Health Service; ICSI, Institute for Clinical Systems Improvement; MPG, Maudsley Prescribing Guidelines in Psychiatry; NICE, National Institute for Health and Clinical Excellence; RANZCP, Royal Australian and New Zealand College of Psychiatrists; TMAP, Texas Medication Algorithm Project; WFSBP, World Federation of Societies of Biological Psychiatry.
aGuideline parts I and II are considered together in this review